FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2090957934> ?p ?o ?g. }

• W2090957934 endingPage "968" @default.
• W2090957934 startingPage "961" @default.
• W2090957934 abstract "Neuroleptic compounds may affect the immune system through a variety of mechanisms. Most possess a complex pharmacology, which makes specific, causal relationships difficult to discern. In this study, a series of experiments was performed to examine the effects of dopamine antagonists on a battery of immunologic parameters. Mitogen-induced lymphocyte proliferation in vitro was inhibited by haloperidol, chlorpromazine, and trifluoperazine at 10, 1 and 1 microM concentrations, respectively. Sulpiride and metoclopramide had no direct effect in vitro. In vivo lymphocyte proliferation was significantly reduced by chlorpromazine at the highest tested doses (12.5 and 15 mg/kg) and by trifluoperazine at the highest tested dose (30 mg/kg). All other dopamine antagonists had no significant effect on in vivo lymphocyte proliferation. A murine graft vs host (GVH) response was unaffected by haloperidol, sulpiride, and metoclopramide. Chlorpromazine and trifluoperazine exhibited significant inhibition of the GVH response at the highest doses only (15 and 30 mg/kg, respectively). In a picryl chloride induced delayed type hypersensitivity (DTH) assay, haloperidol, metoclopramide, and sulpiride had no effect. However, both chlorpromazine and trifluoperazine significantly reduced DTH-induced paw swelling at the higher doses (7.5 mg/kg, and 10 and 30 micrograms/kg, respectively). These studies indicate that the more specific dopamine antagonists (e.g. sulpiride, metoclopramide, and haloperidol) do not share the immunologic profiles of chlorpromazine and trifluoperazine, suggesting that these effects of chlorpromazine and trifluoperazine are not related to their dopamine antagonist properties." @default.
• W2090957934 created "2016-06-24" @default.
• W2090957934 creator A5014916727 @default.
• W2090957934 creator A5027185674 @default.
• W2090957934 creator A5032362159 @default.
• W2090957934 creator A5043851781 @default.
• W2090957934 creator A5079045304 @default.
• W2090957934 date "1991-01-01" @default.
• W2090957934 modified "2023-09-24" @default.
• W2090957934 title "Dissociation of immunosuppression by chlorpromazine and trifluoperazine from pharmacologic activities as dopamine antagonists" @default.
• W2090957934 cites W1963907198 @default.
• W2090957934 cites W1965078868 @default.
• W2090957934 cites W1970693619 @default.
• W2090957934 cites W2001868674 @default.
• W2090957934 cites W2005441704 @default.
• W2090957934 cites W2017518129 @default.
• W2090957934 cites W2024932040 @default.
• W2090957934 cites W2054057359 @default.
• W2090957934 cites W2061505856 @default.
• W2090957934 cites W2062461019 @default.
• W2090957934 cites W2107062893 @default.
• W2090957934 cites W2121471670 @default.
• W2090957934 doi "https://doi.org/10.1016/0192-0561(91)90049-d" @default.
• W2090957934 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1684786" @default.
• W2090957934 hasPublicationYear "1991" @default.
• W2090957934 type Work @default.
• W2090957934 sameAs 2090957934 @default.
• W2090957934 citedByCount "26" @default.
• W2090957934 countsByYear W20909579342016 @default.
• W2090957934 countsByYear W20909579342018 @default.
• W2090957934 countsByYear W20909579342019 @default.
• W2090957934 countsByYear W20909579342020 @default.
• W2090957934 countsByYear W20909579342021 @default.
• W2090957934 countsByYear W20909579342022 @default.
• W2090957934 crossrefType "journal-article" @default.
• W2090957934 hasAuthorship W2090957934A5014916727 @default.
• W2090957934 hasAuthorship W2090957934A5027185674 @default.
• W2090957934 hasAuthorship W2090957934A5032362159 @default.
• W2090957934 hasAuthorship W2090957934A5043851781 @default.
• W2090957934 hasAuthorship W2090957934A5079045304 @default.
• W2090957934 hasConcept C120069818 @default.
• W2090957934 hasConcept C126322002 @default.
• W2090957934 hasConcept C134018914 @default.
• W2090957934 hasConcept C137183658 @default.
• W2090957934 hasConcept C150903083 @default.
• W2090957934 hasConcept C185592680 @default.
• W2090957934 hasConcept C207001950 @default.
• W2090957934 hasConcept C2775891158 @default.
• W2090957934 hasConcept C2776978879 @default.
• W2090957934 hasConcept C2778479196 @default.
• W2090957934 hasConcept C2778775820 @default.
• W2090957934 hasConcept C2780806966 @default.
• W2090957934 hasConcept C2780852908 @default.
• W2090957934 hasConcept C2780948584 @default.
• W2090957934 hasConcept C2781353949 @default.
• W2090957934 hasConcept C29688787 @default.
• W2090957934 hasConcept C513476851 @default.
• W2090957934 hasConcept C519063684 @default.
• W2090957934 hasConcept C71924100 @default.
• W2090957934 hasConcept C86803240 @default.
• W2090957934 hasConcept C98274493 @default.
• W2090957934 hasConceptScore W2090957934C120069818 @default.
• W2090957934 hasConceptScore W2090957934C126322002 @default.
• W2090957934 hasConceptScore W2090957934C134018914 @default.
• W2090957934 hasConceptScore W2090957934C137183658 @default.
• W2090957934 hasConceptScore W2090957934C150903083 @default.
• W2090957934 hasConceptScore W2090957934C185592680 @default.
• W2090957934 hasConceptScore W2090957934C207001950 @default.
• W2090957934 hasConceptScore W2090957934C2775891158 @default.
• W2090957934 hasConceptScore W2090957934C2776978879 @default.
• W2090957934 hasConceptScore W2090957934C2778479196 @default.
• W2090957934 hasConceptScore W2090957934C2778775820 @default.
• W2090957934 hasConceptScore W2090957934C2780806966 @default.
• W2090957934 hasConceptScore W2090957934C2780852908 @default.
• W2090957934 hasConceptScore W2090957934C2780948584 @default.
• W2090957934 hasConceptScore W2090957934C2781353949 @default.
• W2090957934 hasConceptScore W2090957934C29688787 @default.
• W2090957934 hasConceptScore W2090957934C513476851 @default.
• W2090957934 hasConceptScore W2090957934C519063684 @default.
• W2090957934 hasConceptScore W2090957934C71924100 @default.
• W2090957934 hasConceptScore W2090957934C86803240 @default.
• W2090957934 hasConceptScore W2090957934C98274493 @default.
• W2090957934 hasIssue "7" @default.
• W2090957934 hasLocation W20909579341 @default.
• W2090957934 hasLocation W20909579342 @default.
• W2090957934 hasOpenAccess W2090957934 @default.
• W2090957934 hasPrimaryLocation W20909579341 @default.
• W2090957934 hasRelatedWork W1974196669 @default.
• W2090957934 hasRelatedWork W2013378704 @default.
• W2090957934 hasRelatedWork W2016027699 @default.
• W2090957934 hasRelatedWork W2069098762 @default.
• W2090957934 hasRelatedWork W2075004169 @default.
• W2090957934 hasRelatedWork W2080984727 @default.
• W2090957934 hasRelatedWork W2086717368 @default.
• W2090957934 hasRelatedWork W2090957934 @default.
• W2090957934 hasRelatedWork W2092794408 @default.
• W2090957934 hasRelatedWork W2255883432 @default.
• W2090957934 hasVolume "13" @default.

• next